Mikaela Smit is a Research Fellow at the Department of Infectious Disease Epidemiology. She specialise as an epidemiologist and mathematical modeller, working on the interface between research and policy. Her work focuses on utilising large health care cohort data, surveillance data and health system data to construct micro-simulation models of health, especially in high HIV-prevalence countries with two research aims. Firstly, to evaluate the patterns of infectious and non-communicable diseases now and future trends of these. Secondly to compare the impact of different preventative and screening and treatment services on individual and population health. Output from this work helps support policy makers to prepare for future care needs and identify opportunities for service expansion. Ultimately, this work aims to inform how HIV platforms can be leveraged in the transition to providing Universal Health Coverage and define essential packages of health.
Mikaela also hold an honorary position at the HIV Monitoring Foundation in the Netherlands. She has worked closely with the Dutch HIV cohort data, carried out modelling work, projecting the future non-communicable disease burden of patients ageing with HIV (in particular cardiovascular disease) and evaluating impact of interventions for policy guidance in The Netherlands.
et al., 2017, Projections of Non-Communicable Disease and Health Care Costs Among HIV-Positive Persons in Italy and the U.S.A: A Modelling Study, PLOS One, Vol:12, ISSN:1932-6203
et al., 2017, Cardiovascular disease prevention policy in HIV: recommendations from a modelling study, Clinical Infectious Diseases, Vol:66, ISSN:1058-4838, Pages:743-750
et al., 2015, Future challenges for clinical care of an ageing population infected with HIV: a modelling study, Lancet Infectious Diseases, Vol:15, ISSN:1473-3099, Pages:810-818
et al., 2013, Changes in First-Line cART Regimens and Short-Term Clinical Outcome between 1996 and 2010 in The Netherlands, PLOS One, Vol:8, ISSN:1932-6203
et al., 2012, Could better tolerated HIV drug regimens improve patient outcome?, AIDS, Vol:26, ISSN:0269-9370, Pages:1953-1959
et al., 2011, New Drugs Trageting Toxicities Have HIghest Hope of Impacting Patients Prognosis, International Society for Sexually Transmitted Diseases Research